Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase InhibitorEmily Borretto, Loretta Lazzarato, Francesco Spallotta, et al.
Frontiers in Pharmacology|June 20, 2018
Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer CellsElena Gazzano, Loretta Lazzarato, Barbara Rolando, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidatesBarbara Rolando, Loretta Lazzarato, Antonella Di Stilo, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial DamageElisabetta Marini, Barbara Rolando, Federica Sodano, et al.
ACS Chemical Biology|June 20, 2017
Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine ProductionWee Han Poh, Nicolas Barraud, Stefano Guglielmo, et al.
Journal of Biomolecular Screening|September 18, 2012
A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivativesGeorgia E Tsotsou, Giovanna Di Nardo, Sheila J Sadeghi, et al.
Journal of Medicinal Chemistry|May 15, 2009
Synthesis of some novel organic nitrates and comparative in vitro study of their vasodilator profileKonstantin Chegaev, Loretta Lazzarato, Paolo Marcarino, et al.
Biological Chemistry|March 3, 2023
New lipophilic organic nitrates: candidates for chronic skin disease therapyElisabetta Marini, Federica Sodano, Barbara Rolando, et al.
Chemistry & Biodiversity|March 26, 2009
Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterizationDonatella Boschi, Loretta Lazzarato, Barbara Rolando, et al.
Oxidative Medicine and Cellular Longevity|April 3, 2015
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusionFausto Chiazza, Konstantin Chegaev, Mara Rogazzo, et al.
Pageof 9